In our in vivo models, the combination of CPT-11 with anti-HGF antibody showed a potent anti-cancer effect on human colorectal cancer, as evidenced by the strong inhibition of tumor growth and interference with c-MET signal transduction. The gene discussed is MET; the disease is colorectal cancer.